Compare Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-pCR Patients With HER2 Positive Early Breast Cancer
Clinical trial NCT05292742 · RECRUITING
Trial details
- NCT number
- NCT05292742
- Sponsor
- Fujian Medical University Union Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-02
- Primary completion
- 2026-10-01
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.